Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc is a leading biopharmaceutical company that specializes in discovering and developing RNA-targeted therapeutics for rare and serious diseases. Their unique platform technology allows for precise targeting of disease-causing genes, resulting in successful drugs like Spinraza, the first FDA-approved treatment for spinal muscular atrophy. Ionis has a strong pipeline of potential therapies in various stages of development, targeting diseases like Huntington's disease, amyotrophic lateral sclerosis, and cardiovascular disease. The company is dedicated to improving patients' lives through innovative science and collaboration with healthcare professionals.